An observational study in SARS-CoV Infection, Seroprevalence and Covid19, sponsored by University of Cagliari. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-09.
Sponsored by University of Cagliari · Observational
The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.
382 studies on the registry are indexed under Severe Acute Respiratory Syndrome; 14 are open to participants now.
This study's enrollment of 121 is below the median of 300 across 140 observational studies indexed under Severe Acute Respiratory Syndrome.
Browse Severe Acute Respiratory Syndrome studies →University of Cagliari is the lead sponsor of 82 studies on the registry; 17 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
This is a cohort of elective surgical patients admitted to our unit in the 2020 fall period
Exclusion Criteria:
Serologic test for both SARS-COV-2 IgG and IgM
SARS-COV-2 seroprevalence
SARS-COV-2 IgG and IgM seroprevalence between spring and fall period
Time frame: 1St September - 10Th December 2020
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Severe Acute Respiratory Syndrome→
University of Cagliari